Gilead Sciences
Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About GILD
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.
GILD Key Statistics
Stock Snapshot
As of today, Gilead Sciences(GILD) shares are valued at $131.65. The company's market cap stands at 162.4B, with a P/E ratio of 19.00 and a dividend yield of 2.5%.
As of 2026-05-01, Gilead Sciences(GILD) stock has fluctuated between $127.96 and $132.21. The current price stands at $131.65, placing the stock +2.9% above today's low and -0.4% off the high.
Gilead Sciences(GILD) shares are trading with a volume of 6.49M, against a daily average of 5.96M.
During the past year, Gilead Sciences(GILD) stock moved between $95.30 at its lowest and $157.29 at its peak.
During the past year, Gilead Sciences(GILD) stock moved between $95.30 at its lowest and $157.29 at its peak.
GILD News
Gilead Sciences (NasdaqGS:GILD) received FDA acceptance and priority review for its New Drug Application for a once daily HIV regimen. The company also complet...
With no single headline event driving Gilead Sciences (GILD) today, the focus shifts to how the stock’s recent performance, business mix and valuation metrics m...
Gilead (GILD) Sciences announced the U.S. Food and Drug Administration, FDA, accepted its New Drug Application, NDA, submission for bictegravir 75 mg/lenacapavi...
Analyst ratings
75%
of 32 ratingsMore GILD News
Technical Analysis Gilead Sciences Crosses Critical Breakout Level. The Stock Can Gain 35% From Here. In this article GILD XBI IBB Gilead headquarters in Foster...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Gilead Sciences (GILD) announced the completion of its previously announced acquisition of Arcellx (ACLX). Under the terms of the transaction, Gilead acquired A...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.